Hosted on MSN6mon
FDA warns Serena Williams migraine drug ad is misleadingAbbVie reported that sales from Ubrelvy and a similar migraine medication called Qulipta ... health perspective because the TV ad, featuring Serena Williams, misleadingly suggests that Ubrelvy ...
Pharma giant AbbVie has been taken to task by the FDA for running an ad for one of its migraine drugs, featuring tennis star Serena Williams, which the agency says overstates its efficacy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback